[Secondary prevention of gastric cancer in a risk group of persons without gastric acid. 2nd communication (author's transl)].
More than 6,000 predominant unselected persons were examined by tubeless gastric acid test using the "Desmoidpille" and by simultaneous determination of uropepsin according to West et al. About 1,000 probands demonstrating a lacking acid secretion were recognized as risk group and taken into supervision over several years since 1972. In this risk group 20 cases of gastric cancer were detected, 9 of them already by first investigation. 5 gastric cancers were found during the follow-up as true early gastric cancers. In 5,200 probands without risk signs (normal acid test) only 6 cases of gastric cancer were observed during time of follow-up. So it is a high risk group indeed, we have selected. Regarding the casuistry of 7 persons, younger than 70 years of age, with gastric cancer detected during follow-up, 4 of them survived, such a dispensaire included in a general geriatric care seems useful to practice.
D000368:Aged; D004207:Dispensatories as Topic; D010450:Endopeptidases / Q000032:analysis; D005750:Gastric Juice / Q000378:metabolism*; D005756:Gastritis / Q000150:complications; D006801:Humans; D008875:Middle Aged; D012306:Risk; D013274:Stomach Neoplasms / Q000517:prevention & control*
D010450:Endopeptidases; C100308:uropepsin
rärvention